⌘K

Login Start Free

Home/Filings/4/0001209191-20-020087

4//SEC Filing

AKER HAZEL M 4

Accession 0001209191-20-020087

CIK 0001260990other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 6:46 PM ET

Size

5.3 KB

Accession

0001209191-20-020087

Insider Transaction Report

Form 4

Period: 2020-03-17

Oncternal Therapeutics, Inc.ONCT

General Counsel

Transactions

Award
Stock Option
2020-03-17−11,080→ 11,080 total
Exercise: $3.33Exp: 2030-03-17→ Common Stock (11,080 underlying)

Footnotes (1)

[F1]Fully vested on grant date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1

filerCIK 0001265783

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 6:46 PM ET
Size: 5.3 KB

View on SEC.gov